periodic oscillatory neuronal activity at low frequency, highly correlated with tremor, was detected in a large number of cells in STN and GPi after MPTP treatment and the autocorrelograms of spike trains of these neurons confirm that the periodic oscillatory activity was very stable.
Abstract:
1. The neuronal mechanisms underlying the major motor signs of Parkinson's disease were studied in the basal ganglia of parkinsonian monkeys. Three African green monkeys were systemically treated w...
TL;DR: The hypothesis states that the basal ganglia do not generate movements, and when voluntary movement is generated by cerebral cortical and cerebellar mechanisms, the basal Ganglia act broadly to inhibit competing motor mechanisms that would otherwise interfere with the desired movement.
TL;DR: Electrical stimulation of the subthalamic nucleus is an effective treatment for advanced Parkinson's disease and the severity of symptoms off medication decreases, and the dose of levodopa can be reduced with consequent reduction in dyskinesias.
TL;DR: These findings establish a critical role for basal ganglia circuitry in the bidirectional regulation of motor behaviour and indicate that modulation of direct-pathway circuitry may represent an effective therapeutic strategy for ameliorating parkinsonian motor deficits.
TL;DR: High-frequency deep brain stimulation of the subthalamic nucleus is a powerful method that is currently unchallenged in the management of Parkinson's disease, but its long-term effects must be thoroughly assessed.
TL;DR: Local potentials from the globus pallidus interna and subthalamic nucleus are recorded in four awake patients after neurosurgery for Parkinson's disease to demonstrate synchronization of activity does occur between pallidum and STN, and its pattern is critically dependent on the level of dopaminergic activity.
TL;DR: A model in which specific types of basal ganglia disorders are associated with changes in the function of subpopulations of striatal projection neurons is proposed, which suggests that the activity of sub Populations of Striatal projections neurons is differentially regulated by striatal afferents and that different striatal projections may mediate different aspects of motor control.
TL;DR: This paper describes the changes in neuronal activity in the motor circuit in animal models of hypo- and hyperkinetic disorders and postulates specific disturbances within the basal ganglia-thalamocortical 'motor' circuit.
TL;DR: A clinical, morphological and neurochemical correlative study in patients with Parkinson's syndrome and Huntington's chorea is reported in this paper, where positive correlations can be established, within a certain range, between the severity of individual Parkinsonian symptoms (especially akinesia and tremor) and the degree, and also the site, of the disturbance of dopamine metabolism within the nuclei of the basal ganglia; and the sensitivity of the patients to levodopa's acute anti-akinesia effect.
TL;DR: The N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey provides a model that can be used to examine mechanisms and explore therapies of parkinsonism and the pathological and biochemical changes produced by NMPTP are similar to the well-established changes in patients with parkinsonistan.
TL;DR: The postulated role of excessive activity in the subthalamic nucleus in Parkinson's disease is supported by the effects of lesions evaluated in monkeys rendered parkinsonian by treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Q1. What are the contributions in "The primate subthalamic nucleus. ii. neuronal activity in the mptp model of parkinsonism" ?
1. The neuronal mechanisms underlying the major motor signs of Parkinson ’ s disease were studied in the basal ganglia of parkinsonian monkeys. 8. The duration of extracellularly recorded action potentials significantly increased with the MPTP treatment ( from 0. 67 t 0. 1 to 0. 81 t_ 0. 2 ms in STN and from 0. 73 t_ 0. 1 to 0. 8 t 0. 1 ms in GPi ).
Q2. What is the effect of the MPTP treatment on the thalamocortical neurons?
Increased inhibition of thalamocortical neurons by GPi output may eventually result in akinesia and rigidity, whereas periodic oscillatory activity in the cortico-STN-GPi-thalamic circuitry is possibly involved in the development of parkinsonian tremor.
Q3. What is the frequency of the periodic bursts?
5. Periodic oscillatory neuronal activity at low frequency, highly correlated with tremor, was detected in a large number of cells in STN and GPi after MPTP treatment (average oscillation frequency 6.0 and 5.1 Hz, respectively).
Q4. What is the average firing rate of neurons in the subthalamic nucleus of par?
In the normal state the percentage of neurons with burst discharges (as defined by autocorrelation analysis) was 69% and 78% in STN and GPi, respectively.
Q5. What is the name of the book?
Three African green monkeys were systemically treated with 1 -methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP) until parkinsonian signs, including akinesia, rigidity, and a prominent 4- to ~-HZ tremor, appeared.
Q6. What is the average frequency of periodic bursts in GPi?
6. Neurons discharging with periodic bursts at frequencies between 8 and 20 Hz (average 14.4 Hz in STN and 10.5 Hz in GPi) were also detected more often after MPTP.
Q7. How much did the percentage of cells with periodic activity increase?
The percentage of cells with 4- to ~-HZ periodic activity significantly increased from 2% to 16% in STN and from 0.6% to 25% in GPi with the MPTP treatment.
Q8. What is the effect of the MPTP treatment on the striatum?
These results support a model in which dopaminergic denervation of the basal ganglia (possibly including extrastriatal sites) leads to increased tonic and phasic activity in STN and GPi.
Q9. What is the average duration of the bursts?
The duration of extracellularly recorded action potentials significantly increased with the MPTP treatment (from 0.67 t 0.1 to 0.81 t_ 0.2 ms in STN and from 0.73 t_ 0.1 to 0.8 t 0.1 ms in GPi).